FABRIS, BRUNO
 Distribuzione geografica
Continente #
NA - Nord America 13.205
EU - Europa 7.122
AS - Asia 1.760
SA - Sud America 39
AF - Africa 37
Continente sconosciuto - Info sul continente non disponibili 23
OC - Oceania 13
Totale 22.199
Nazione #
US - Stati Uniti d'America 13.149
PL - Polonia 2.603
SE - Svezia 1.256
IT - Italia 1.014
UA - Ucraina 851
CN - Cina 588
HK - Hong Kong 435
FI - Finlandia 299
TR - Turchia 288
SG - Singapore 266
DE - Germania 200
BG - Bulgaria 181
IE - Irlanda 178
GB - Regno Unito 173
FR - Francia 77
CH - Svizzera 71
BE - Belgio 62
KR - Corea 53
VN - Vietnam 46
CZ - Repubblica Ceca 41
NL - Olanda 37
CA - Canada 36
BR - Brasile 26
IN - India 22
RU - Federazione Russa 22
ES - Italia 19
EU - Europa 18
MX - Messico 18
SN - Senegal 18
JP - Giappone 11
MY - Malesia 11
AT - Austria 10
EG - Egitto 10
IR - Iran 10
AU - Australia 8
ID - Indonesia 8
RO - Romania 6
AR - Argentina 5
NZ - Nuova Zelanda 5
CD - Congo 4
CL - Cile 4
IL - Israele 4
SI - Slovenia 4
TH - Thailandia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
GR - Grecia 3
SA - Arabia Saudita 3
AM - Armenia 2
BY - Bielorussia 2
EC - Ecuador 2
KZ - Kazakistan 2
LU - Lussemburgo 2
MA - Marocco 2
MD - Moldavia 2
NO - Norvegia 2
RS - Serbia 2
XK - ???statistics.table.value.countryCode.XK??? 2
ZA - Sudafrica 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BD - Bangladesh 1
CO - Colombia 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GH - Ghana 1
HR - Croazia 1
LA - Repubblica Popolare Democratica del Laos 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
PK - Pakistan 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TW - Taiwan 1
Totale 22.199
Città #
Warsaw 2.601
Woodbridge 1.723
Fairfield 1.549
Houston 1.350
Ann Arbor 1.271
Chandler 1.237
Ashburn 942
Jacksonville 770
Wilmington 755
Seattle 621
Cambridge 503
Hong Kong 430
Princeton 321
Trieste 278
Izmir 252
Beijing 207
Sofia 180
Dublin 170
Singapore 149
Boardman 137
Dearborn 121
San Diego 86
Bern 68
Brussels 59
Düsseldorf 53
Milan 52
Des Moines 49
Seoul 48
Falls Church 47
Dong Ket 46
Helsinki 44
Washington 44
Columbus 39
Jinan 37
Nanjing 34
Norwalk 34
Kocaeli 33
Redmond 31
Redwood City 28
Phoenix 27
Shanghai 26
Dallas 25
Los Angeles 25
Mestre 25
Venezia 24
Bremen 22
Chicago 22
Verona 21
Prague 20
Rome 19
Dakar 18
Hefei 18
New York 18
Brno 17
Buffalo 17
London 16
Kunming 14
Shenyang 14
Fremont 13
Fuzhou 13
Nanchang 13
Segrate 13
Munich 12
São Paulo 12
Toronto 12
Duino-Aurisina 11
Dongguan 10
Guangzhou 10
Hebei 10
Pune 10
Auburn Hills 9
Edinburgh 9
Hangzhou 9
Omegna 9
Tappahannock 9
San Francisco 8
Vienna 8
Chongqing 7
Indiana 7
Mogliano Veneto 7
Renton 7
St. Catharines 7
Tokyo 7
Zhengzhou 7
Amsterdam 6
Genova 6
Madrid 6
Tomares 6
Torviscosa 6
Baotou 5
Changsha 5
Frankfurt am Main 5
Grafing 5
Jakarta 5
Milpa Alta 5
Naples 5
Omaha 5
Paris 5
Torino 5
Udine 5
Totale 17.121
Nome #
Aldosterone effects on glomerular structure and function 377
Roles and Clinical Applications of OPG and TRAIL as Biomarkers in Cardiovascular Disease 368
Radiofrequency ablation compared to surgery for the treatment of benign thyroid nodules 364
A case report of malignant hypertension in a young woman 353
Surgical and pathological changes after radiofrequency ablation of thyroid nodules 346
A new ultrasonographic instrument for measuring vessel wall shear stress. 341
Update on RAAS Modulation for the Treatment of Diabetic Cardiovascular Disease 341
TRAIL Modulates the Immune System and Protects against the Development of Diabetes 335
Association between thyroid hormones and TRAIL 323
Circulating osteoprotegerin is associated with chronic kidney disease in hypertensive patients 318
A prospective study on the efficacy of patient simulation in heart and lung auscultation 311
A case report of hyponatremia after surgery for Conn's adenoma 298
Usefulness of core needle biopsy for the diagnosis of thyroid Burkitt's lymphoma: a case report and review of the literature 275
Quantitative value of aldosterone-renin ratio for detection of aldosterone-producing adenoma: The Aldosterone-Renin Ratio for Primary Aldosteronism (AQUARR) study 266
The complex interplay between lipids, immune system and interleukins in cardio-metabolic diseases 260
Patient satisfaction after thyroid RFA versus surgery for benign thyroid nodules: a telephone survey 253
A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. 240
Albumin permeability in isolated glomeruli in incipient experimental diabetes mellitus. 228
Large-artery hemodynamics after acute alcohol administration in young, healthy volunteers 222
Cross-sex hormone therapy for gender dysphoria 214
Systemic and regional haemodynamic effects of aortofemoral angiography 193
Osteoprotegerin induces morphological and functional alterations in mouse pancreatic islets. 191
Ambulatory Blood Pressure Monitoring-Derived Short-Term Blood Pressure Variability in Primary Aldosteronism 188
Innate immunity, through late complement components activation, contributes to the development of early vascular inflammation and morphologic alterations in experimental diabetes. 183
Osteoprotegerin increases in metabolic syndrome and promotes adipose tissue proinflammatory changes 183
TRAIL shows potential cardioprotective activity. 178
Angiotensin 1-7 significantly reduces diabetes-induced leukocyte recruitment both in vivo and in vitro 177
Adrenalectomy Lowers Incident Atrial Fibrillation in Primary Aldosteronism Patients at Long Term 176
Peripheral adrenoceptors in hypotension of hemodialyzed uremic patients. 172
Treatment with n-3 Polyunsaturated Fatty Acids Reverses Endothelial Dysfunction and Oxidative Stress in Experimental Menopause 172
Influence of carotid atherosclerotic plaques on pulse wave assessment with arterial tonometry 171
Haemoconcentration, shear-stress increase and carotid artery diameter regulation after furosemide administration in older hypertensives 170
Radiofrequency ablation for benign thyroid nodules 170
Ambulatory Arterial Stiffness Indexes in Acromegaly. 169
Ambulatory arterial stiffness indices and non-alcoholic fatty liver disease in essential hypertension. 168
12-month efficacy of a single radiofrequency ablation on autonomously functioning thyroid nodules 167
Stimulation of cardiac apoptosis in ovariectomized hypertensive rats: potential role of the renin-angiotensin system 164
Cardiac and nephroprotective effects of angiotensin converting enzyme inhibitor treatment in the renal ablation model. 164
TNF-related apoptosis-inducing ligand significantly attenuates metabolic abnormalities in high-fat-fed mice reducing adiposity and systemic inflammation 162
Prevention of accelerated atherosclerosis by AT1 receptor blockade in experimental renal failure. 161
Glomerular permeability defect in hypertension is dependent on renin angiotensin system activation. 160
Interaction between atrial natriuretic peptide and the renin angiotensin aldosterone system. Endogenous antagonists 157
Exploratory case-control study on ACE2 expression in children with short stature 157
Supplementation of Omega-3 Polyunsaturated Fatty Acids Prevents Increase in Arterial Stiffness After Experimental Menopause 156
Full-Thickness Skin Burn Caused by Radiofrequency Ablation of a Benign Thyroid Nodule 156
Rationality in prophylactic central neck dissection in clinically node-negative (cN0) papillary thyroid carcinoma: Is there anything more to say? A decade experience in a single-center 156
The cardiac renin-angiotensin system in heart failure 155
DOSE AND TIME-DEPENDENT APOPTOTIC EFFECTS BY ANGIOTENSIN II INFUSION ON LEFT VENTRICULAR CARDIOMYOCYTES. 153
Characterization and significance of ACE2 and Mas receptor in human colon adenocarcinoma. 153
Partial thyroidectomy for papillary thyroid microcarcinoma: Is completion total thyroidectomy indicated? 153
Baroreceptor-heart rate reflex sensitivity enhancement after urinary bladder distention in essential hypertensives 150
Mechanics of the carotid artery wall and baroreflex sensitivity after acute ethanol administration in young healthy volunteers 149
Baroreflex sensitivity and central hemodynamics after omega-3 polyunsaturated fatty acids supplementation in an animal model of menopause 149
Coexistence of chronic lymphocytic thyroiditis and papillary thyroid carcinoma. Impact on presentation, management, and outcome 149
Nonalcoholic fatty liver disease in primary aldosteronism: a pilot study 148
Angiotensin-converting enzyme 2 regulates renal atrial natriuretic peptide through angiotensin-(1-7) 147
Il Transessualismo: identificazione di un percorso diagnostico e terapeutico. Kurtis Editrice, Milano 1999. 146
TRAIL as biomarker and potential therapeutic tool for cardiovascular diseases 145
Within-patient reproducibility of the aldosterone: renin ratio in primary aldosteronism. 144
Genetic polymorphisms of the renin-angiotensin-aldosterone system and renal insufficiency in essential hypertension 142
Systemic tumor necrosis factor-related apoptosis-inducing ligand delivery shows antiatherosclerotic activity in apolipoprotein E-null diabetic mice 141
A pheochromocytoma with high adrenocorticotropic hormone and a silent lung nodule. 139
Antihypertensive activity of arylidenaminoguanidine derivatives. 139
ACE2 deficiency shifts energy metabolism towards glucose utilization 139
High-salt diet increases glomerular ACE/ACE2 ratio leading to oxidative stress and kidney damage 139
Baroreflex function after therapy withdrawal in patients with essential hypertension 137
Dyslipidemia and Diabetes Increase the OPG/TRAIL Ratio in the Cardiovascular System 137
Ambulatory blood pressure monitoring-derived short-term blood pressure variability is increased in Cushing's syndrome. 137
High salt diet ameliorates effects of angiotensin converting enzyme inhibition in spontaneously hypertensive streptozotocin diabetic rats 136
Acute effects of intravenous infusions of alcohol on baroreceptor sensitivity in essential hypertension. 135
Reduction of blood pressure in obese hyperinsulinaemic hypertensive patients during somatostatin infusion 134
Ambulatory blood pressure monitoring-derived short-term blood pressure variability in primary hyperparathyroidism 134
Orally administered microencapsulated lysozyme downregulates serum AGE and reduces the severity of early-stage diabetic nephropathy 133
Control of glomerular hyperfiltration and renal hypertrophy by an angiotensin converting enzyme inhibitor prevents the progression of renal damage in hypertensive diabetic rats 133
An increased osteoprotegerin serum release characterizes the early onset of diabetes mellitus and may contribute to endothelial cell dysfunction. 133
Changes in cardiac angiotensin converting enzyme after myocardial infarction and hypertrophy in rats 132
Platelet alpha 2-adrenoceptor modifications induced by long-term treatment with indapamide in essential hypertension. 131
Nonalcoholic fatty liver disease, adiponectin and insulin resistance in dipper and nondipper essential hypertensive patients. 130
Contribution of Systemic Blood-pressure To Myocardial Remodeling In Uremic Rats 130
Body mass index predicts plasma aldosterone concentrations in overweight-obese primary hypertensive patients. 128
Effects of prolonged high-altitude exposure on peripheral adrenergic receptors in young healthy volunteers. 128
Aldosterone does not modify gene expression in human endothelial cells. 127
TRAIL reduces impaired glucose tolerance and NAFLD in the high-fat diet-fed mouse 127
Relationship between mechanical properties of the carotid artery wall and baroreflex function in acutely treated hypertensive patients 126
Human full-length osteoprotegerin induces the proliferation of rodent vascular smooth muscle cells both in vitro and in vivo. 123
Salt blocks the renal benefits of ramipril in diabetic hypertensive rats 122
Inhibition of angiotensin converting enzyme (ACE) in plasma and tissue 121
Inhibition of angiotensin converting enzyme (ACE) in plasma and tissues: studies ex vivo after administration of ACE inhibitors 121
null 120
Ace inhibition in renal disease: risks and benefits. 120
Localization of angiotensin converting enzyme in rat heart 118
Treatment with recombinant tumor necrosis factor-related apoptosis-inducing ligand alleviates the severity of streptozotocin-induced diabetes 118
[Activity and number of lymphocyte beta adrenergic receptors after protracted treatment with mepindolol sulfate of patients with essential arterial hypertension]. 117
Regional hemodynamic effects of slow-release nicardipine in elderly patients with hypertension: evaluation by a new ultrasound technique. 117
Hypertension and diabetes: emphasis on the renin-angiotensin system in atherosclerosis 116
Apoptosis-inducing molecules and uses therefor 116
Regional and systemic haemodynamic response to aortography in hypertensives. 114
Effects of central alpha 2-adrenergic agonists on systemic haemodynamics and on baroreceptor reflex sensitivity in spontaneously hypertensive rats. 114
Comparison of the captopril and the saline infusion test for excluding aldosterone-producing adenoma. 113
Ambulatory Arterial Stiffness Indexes in Cushing’s Syndrome 113
Totale 17.625
Categoria #
all - tutte 57.167
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.167


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204.465 0 228 225 737 325 622 468 480 495 405 296 184
2020/20213.246 296 217 280 356 229 345 408 257 143 345 126 244
2021/20222.291 77 120 114 264 114 226 133 69 228 235 170 541
2022/20233.497 350 507 348 485 235 594 23 310 366 55 155 69
2023/20242.064 161 137 149 96 213 236 355 302 69 50 149 147
2024/2025128 92 36 0 0 0 0 0 0 0 0 0 0
Totale 22.899